2012 annual financial data
Karyopharm Therapeutics 2012 Operating margin
Direct answer
Operating margin was -2,506.31%.
Operating income was -15,890,000 USD and net income was -15,888,000 USD.
Operating cash flow was -15,509,000 USD.
Get free Karyopharm Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 634,000 USD
- Operating income
- -15,890,000 USD
- Net income
- -15,888,000 USD
- Operating cash flow
- -15,509,000 USD